Targeted Modulation of YAP Signaling: Advancing Small-Molecule Strategies in Oncology and Tissue Regeneration
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
Small molecules can now target the Hippo-YAP pathway, a key regulator of tissue growth and cancer. This breakthrough offers new therapeutic strategies for oncology and regenerative medicine.
Area of Science:
- Molecular Biology
- Oncology
- Drug Discovery
Background:
- The Hippo-YAP pathway is crucial for tissue homeostasis and cancer development.
- Conventional drugs struggle to target this pathway effectively.
- YAP (Yes-associated protein) is a key effector in this pathway.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
